The FDA approved the adenoviral vector-based immunotherapy, zopapogene imadenovec-drba, for treatment of certain patients ...

The U.S. Food and Drug Administration has approved Precigen's immunotherapy to treat adults with a rare respiratory disease, making it the first treatment for the condition to receive the health ...

Teddi Mellencamp looked for advice while sharing she was "full of anxiety" amid her immunotherapy treatment. The Real ...

Teddi's followers have her back. The post Teddi Mellencamp Experiencing ‘Severe Anxiety’ Amid Immunotherapy Treatment ...

Papzimeos is the first immunotherapy approved for recurrent respiratory papillomatosis, a rare lung disorder involving the ...

A medication often prescribed to reduce symptoms among people with lung cancer limits the effectiveness of certain treatments ...

Although this was a negative study, I think the data shown here contribute to our knowledge of IO treatments in urothelial cancer,” said Michiel Van der Heijden, MD, PhD.

Bain Capital, 65 Equity Partners, Arlington Capital Partners and Revelstoke Capital Partners are among the PE firms investing in the immunotherapy sector.

Selected patients with a clinical response after therapy could benefit from salvage surgery in non–small cell lung cancer (NSCLC), with acceptable results for perioperative morbidity.

A new study has identified a set of plasma proteins that can predict whether patients with triple-negative breast cancer ...

"Real Housewives of Beverly Hills" alum Teddi Mellencamp said she's dealing with anxiety “on random days for no apparent ...

Teddi Mellencamp says she is 'taking a little break' from immunotherapy amid her stage 4 cancer treatments after she learned they were the reason why she was recently feeling sick.